Evidence map›Paper›PMID 8976179›Full record

ArticleThe Journal of experimental medicine1996

Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.

N M Valiante, J H Phillips, L L Lanier, P Parham

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Suppressing the killer instinct.Science signaling · 2016
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. ITAMs versus ITIMs: striking a balance during cell regulation.The Journal of clinical investigation · 2002
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

N M ValianteDepartment of Structural Biology, Stanford University Medical School, California 94305, USA.
J H Phillips
L L Lanier
P Parham
Stanford University · US

Funding

INTERACTIONS BETWEEN HLA CLASS I &CYTOLYTIC LYMPHOCYTESR01AI022039 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2017
$5.2M
NIAID NIH HHS AI 22039NIAID NIH HHS R01 AI022039
6 · The paper itself

Abstract

The killer cell inhibitory receptors (KIR) of human natural killer (NK) cells recognize human leukocyte antigen class I molecules and inhibit NK cell cytotoxicity through their interaction with protein tyrosine phosphatases (PTP). Here, we report that KIR recognition of class I ligands inhibits distal signaling events and ultimately NK cell cytotoxicity by blocking the association of an adaptor protein (pp36) with phospholipase C-gamma in NK cells. In addition, we demonstrate that pp36 can serve as a substrate in vitro for the KIR-associated PTP, PTP-1C (also called SHP-1), and that recognition of class I partially disrupts tyrosine phosphorylation of NK cell proteins, providing evidence for KIR-induced phosphatase activity.

Indexed as

Adaptor Proteins, Signal TransducingCalciumGRB2 Adaptor ProteinHLA-B AntigensHumansInositol 1,4,5-TrisphosphateIsoenzymesKiller Cells, NaturalKineticsPhosphotyrosineProtein Kinase CProteinsReceptors, ImmunologicSignal TransductionTransfectionAdaptor Proteins, Signal TransducingCalciumGRB2 Adaptor ProteinGRB2 protein, humanHLA-B AntigensInositol 1,4,5-TrisphosphateIsoenzymesPhosphotyrosineProtein Kinase Cprotein kinase C gammaProteinsReceptors, Immunologic

Identifiers

PMID8976179
PMCPMC2196393
OpenAlexW2113536356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.